Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Chunghwa Telecom
CHT
$32.8B
| $57.1M | 0.01% |
1,547,359
+57,681
| +4% | +$2.13M |
|
927
COPT Defense Properties
CDP
$4.14B
| $57.1M | 0.01% |
1,942,635
-80,137
| -4% | -$2.34M |
|
|
B
928
DELISTED
Barnes Group Inc.
B
| $57M | 0.01% |
920,666
-14,090
| -2% | -$814K |
|
|
ELME
929
Elme Communities
ELME
$144M
| $56.8M | 0.01% |
1,947,249
-17,111
| -0.9% | -$509K |
|
930
Simmons First National
SFNC
$3.4B
| $56.6M | 0.01% |
2,112,565
+315,996
| +18% | +$7.97M |
|
931
Sarepta Therapeutics
SRPT
$1.81B
| $56.6M | 0.01% |
438,341
+2,606
| +0.6% | +$263K |
|
932
FirstCash
FCFS
$9.05B
| $56.5M | 0.01% |
701,114
-46,428
| -6% | -$3.9M |
|
933
Kemper
KMPR
$1.55B
| $56.5M | 0.01% |
728,824
-4,176
| -0.6% | -$311K |
|
934
Williams-Sonoma
WSM
$29.5B
| $56.5M | 0.01% |
1,537,832
+6,572
| +0.4% | +$228K |
|
935
Kennametal
KMT
$2.41B
| $56.4M | 0.01% |
1,529,475
-4,860
| -0.3% | -$163K |
|
|
KW
936
DELISTED
Kennedy-Wilson Holdings
KW
| $56.4M | 0.01% |
2,528,220
-83,799
| -3% | -$1.88M |
|
937
Federated Hermes
FHI
$4.71B
| $56.3M | 0.01% |
1,727,071
-47,604
| -3% | -$1.55M |
|
938
Insperity
NSP
$1.96B
| $56.1M | 0.01% |
652,529
-49,751
| -7% | -$4.33M |
|
939
Acuity Brands
AYI
$10.6B
| $56M | 0.01% |
405,712
-51,808
| -11% | -$6.66M |
|
940
SPDR Gold Trust
GLD
$143B
| $55.9M | 0.01% |
391,131
-26,691
| -6% | -$3.73M |
|
941
FNB Corp
FNB
$6.75B
| $55.9M | 0.01% |
4,399,258
+70,947
| +2% | +$870K |
|
942
Emergent Biosolutions
EBS
$229M
| $55.8M | 0.01% |
1,034,592
-33,705
| -3% | -$1.83M |
|
943
IPG Photonics
IPGP
$3.61B
| $55.8M | 0.01% |
384,935
+3,756
| +1% | +$523K |
|
944
Meritage Homes
MTH
$4.69B
| $55.7M | 0.01% |
1,821,518
-29,314
| -2% | -$1.01M |
|
945
Interparfums
IPAR
$3.83B
| $55.5M | 0.01% |
763,888
-6,328
| -0.8% | -$460K |
|
946
UFP Industries
UFPI
$5.01B
| $55.5M | 0.01% |
1,164,272
-61,004
| -5% | -$2.87M |
|
947
Aecom
ACM
$9.42B
| $55.5M | 0.01% |
1,287,201
+105,053
| +9% | +$4.35M |
|
|
GBT
948
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $55.5M | 0.01% |
697,710
-22,655
| -3% | -$1.34M |
|
|
JWN
949
DELISTED
Nordstrom
JWN
| $55.2M | 0.01% |
1,348,859
-125,190
| -8% | -$4.63M |
|
|
TPH
950
DELISTED
Tri Pointe Homes
TPH
| $55.2M | 0.01% |
3,542,508
-62,085
| -2% | -$956K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.